Journal
CELL DEATH DISCOVERY
Volume 7, Issue 1, Pages -Publisher
SPRINGERNATURE
DOI: 10.1038/s41420-021-00598-7
Keywords
-
Categories
Funding
- National Key R&D project of the Chinese Ministry of Science and Technology [2018YFE0205100]
- Key Program of the National Natural Science Foundation of China [U1632270]
- National Natural Science Foundation of China [11675234]
Ask authors/readers for more resources
RBM39, a crucial factor in tumor-targeted mRNA and protein expression, plays a vital role in tumorigenesis and has broad development prospects in clinical treatment and drug research. Its multi-level regulation and molecular function as a splicing factor in most common tumors are systematically outlined, providing reliable ideas for future therapeutic strategies.
RNA-binding motif protein 39 (RBM39), as a key factor in tumor-targeted mRNA and protein expression, not only plays a vital role in tumorigenesis, but also has broad development prospects in clinical treatment and drug research. Moreover, since RBM39 was identified as a target of sulfonamides, it has played a key role in the emerging field of molecule drug development. Hence, it is of great significance to study the interaction between RBM39 and tumors and the clinical application of drug-targeted therapy. In this paper, we describe the possible multi-level regulation of RBM39, including gene transcription, protein translation, and alternative splicing. Importantly, the molecular function of RBM39 as an important splicing factor in most common tumors is systematically outlined. Furthermore, we briefly introduce RBM39's tumor-targeted drug research and its clinical application, hoping to give reference significance for the molecular mechanism of RBM39 in tumors, and provide reliable ideas for in-depth research for future therapeutic strategies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available